4-17614673-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025205.5(MED28):c.19G>A(p.Gly7Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000791 in 1,612,748 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0041 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00045 ( 7 hom. )
Consequence
MED28
NM_025205.5 missense
NM_025205.5 missense
Scores
3
5
10
Clinical Significance
Conservation
PhyloP100: 9.29
Genes affected
MED28 (HGNC:24628): (mediator complex subunit 28) Predicted to enable actin binding activity. Predicted to act upstream of or within negative regulation of smooth muscle cell differentiation and stem cell population maintenance. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009022772).
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED28 | NM_025205.5 | c.19G>A | p.Gly7Ser | missense_variant | 1/4 | ENST00000237380.12 | NP_079481.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED28 | ENST00000237380.12 | c.19G>A | p.Gly7Ser | missense_variant | 1/4 | 1 | NM_025205.5 | ENSP00000237380.6 | ||
MED28 | ENST00000503945.2 | n.10G>A | non_coding_transcript_exon_variant | 1/6 | 1 | ENSP00000426529.1 | ||||
MED28 | ENST00000506409.1 | n.26G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00410 AC: 624AN: 152208Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
624
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00104 AC: 256AN: 246888Hom.: 0 AF XY: 0.000626 AC XY: 84AN XY: 134182
GnomAD3 exomes
AF:
AC:
256
AN:
246888
Hom.:
AF XY:
AC XY:
84
AN XY:
134182
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000447 AC: 653AN: 1460422Hom.: 7 Cov.: 31 AF XY: 0.000378 AC XY: 275AN XY: 726618
GnomAD4 exome
AF:
AC:
653
AN:
1460422
Hom.:
Cov.:
31
AF XY:
AC XY:
275
AN XY:
726618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00408 AC: 622AN: 152326Hom.: 3 Cov.: 33 AF XY: 0.00340 AC XY: 253AN XY: 74486
GnomAD4 genome
AF:
AC:
622
AN:
152326
Hom.:
Cov.:
33
AF XY:
AC XY:
253
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
47
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
162
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Focal segmental glomerulosclerosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Diagnostics Lab, Nemours Children's Health, Delaware | Nov 13, 2019 | This missense variant (c.19G>A, p.Gly75Ser) has been observed at extremely low frequency in population databases (gnomAD) and has not been reported in the literature. Variant prediction programs do not show agreement regarding the effect of this variant. Insufficient evidence exists to classify this change, therefore its significance is uncertain. The change was identified as heterozygous in an affected patient. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at